相关实验视频

Updated: May 22, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

宫腺癌中HER2表达的预后价值:一个回顾性队列研究

Qing Xu^1,2, Zhuomin Yin², Yueqi Li^1,2

¹The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.

Oncology letters

|March 17, 2025

概括

免疫组织化学 (IHC) 单独有效预测宫腺癌的结果,识别人体表皮生长因子受体2 (HER2) 表达. 这种方法为向治疗和改善患者预后提供了洞察力.

科学领域:

在瘤学瘤学.
病理学病理学病理学

背景情况:

人体表皮生长因子受体2 (HER2) 是各种癌症的关键治疗点.
它在宫腺癌的预后价值和治疗潜力仍未得到充分探索.

研究的目的:

研究HER2表达水平与宫腺癌的预后之间的关联.
探索单独使用免疫组织化学 (IHC) 与结合IHC/光 in situ杂交 (FISH) 的实用性,以评估HER2状态.
为 HER2 表达性宫腺癌的向治疗提供见解.

主要方法:

对179名经过手术的宫癌患者的回顾性分析.
使用单独的IHC和IHC/FISH组合来评估HER2状态.
使用了卡普兰-梅尔生存分析,日志等级测试和考克斯回归模型.

主要成果:

检测到HER2表达在44.1%的患者仅使用IHC,而使用IHC/FISH组合检测到5.0%.
HER2表达与晚期,淋巴结转移,血管入侵,癌症抗原125升高和复发率增加相关.
仅由IHC单独表达HER2与较短的无进展生存期 (PFS) 有关.
结合IHC/FISH的HER2阳性也与较差的PFS显著相关.

结论:

使用单独的IHC对HER2状态的分类显示出预测宫腺癌患者的结果的前景.
这种方法可能有助于优化治疗策略并提高HER2表达性宫腺癌的治疗疗效.

关键词:

在HER2中,HER2是HER2.在IHC中,IHC是指IHC.宫腺癌的发生预后预后预后

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...